A Study of PD-1 Inhibitors Combined With Fruquintinib and Chemotherapy in First-line Treatment of HER2-negative Advanced G/GEJ Cancer
Clinical trial NCT06158919 · RECRUITING
Trial details
- NCT number
- NCT06158919
- Sponsor
- Fudan University
- Status
- RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-20
- Primary completion
- 2024-11-20
- Enrollment
- 58
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.